Financial Services
Star Health and Allied Insurance Company Limited (STARHEALTH) clears resistance, moves up 5% intraday
Star Health and Allied Insurance Company Limited (NSE: STARHEALTH) stock price moves up 5% intraday to ₹563.95, clearing its 6M resistance trendline at ₹529.
Star Health and Allied Insurance Company Limited (STARHEALTH) breaks out with a +5% gain, clearing its 6M resistance trendline. This move follows the company’s recent NSE filings on shareholders meeting updates, including the Scrutinizer’s report and voting results of the Postal Ballot. In the insurance sector, STARHEALTH’s breakout aligns with a positive trend, though it stands out with its significant upward move today.
Technical setup — trendlines & DMA
From a technical standpoint, STARHEALTH has established a robust 6M support floor at ₹514.31, currently sitting 8.80% above it. The resistance trendline at ₹528.85 has been decisively cleared by 6.22%, marking a breakout. The 50-DMA at ₹513.1 and the 200-DMA at ₹477.4 both lie below the current price, with the 50-DMA above the 200-DMA, signaling a bullish trend. The stock is trading in the upper third of its 52W range, indicating strong performance relative to its yearly low but still some distance from its high, suggesting room for further upside.
Snapshot: ₹563.95 on 2026-06-18 (chart frozen at publication)
Fundamentals & business context
Despite a PE ratio of 56.2, STARHEALTH’s profit margin of 3.1% and revenue CAGR of 13.3% over the past five years suggest that the market may be pricing in future growth potential rather than current earnings. The company’s institutional ownership of 23.8% indicates a level of confidence from sophisticated investors, though the absence of a specific NSE catalyst today suggests the move may be more technically driven. The declining profit CAGR of -3.4% over the same period, however, raises questions about the sustainability of its current valuation.
Algorithmic scorecard
The algorithmic scorecard reflects a technically strong but fundamentally weaker profile for STARHEALTH. Two of the strongest signals are the bullish trend, with the 50-DMA above the 200-DMA, and the stock’s position above both moving averages, indicating positive momentum. Additionally, the low debt level with a D/E ratio of 0.07 points to excellent financial health. On the flip side, the low profit margin of 3.1% and negligible dividend yield of 0% represent significant risks, highlighting thin profits and lack of income generation for shareholders.
Company outlook
Management’s forward-looking statements from the Q4FY26 earnings call highlight several key points. They expect NEP growth to align with GWP growth in the coming quarters, signaling a potential improvement in profitability. An anticipated 1% to 1.5% yearly increase in volume-based retention suggests efforts to enhance customer loyalty are paying off. The company remains committed to focusing on profitable geographies and consumer cohorts, aiming for sustainable high-teen growth and mid-teen to high-teen ROEs. These strategic initiatives underscore management’s dedication to driving profitable growth.
Get all details on STARHEALTH — P&L, peers, shareholding and more on TradeAlone.
Capital Markets
Motilal Oswal Financial Services Limited (motilalofs) Gets IND Aa+/stable Rating Upgrade by India Ratings
Motilal Oswal Financial Services Limited (MOTILALOFS) receives IND AA+/Stable upgrade from India Ratings, reflecting stronger business profile.
Motilal Oswal Financial Services Limited (MOTILALOFS) announced that India Ratings and Research (Ind-Ra), a Fitch Group company, has upgraded the long-term credit rating of the company and its key subsidiaries to ‘IND AA+’ with a Stable Outlook, from ‘IND AA’ with a Positive Outlook. The upgrade applies to the non-convertible debentures (NCDs) and bank loan facilities of MOFSL and Motilal Oswal Home Finance Limited (MOHFL), and to the NCDs of Motilal Oswal Finvest Limited (MOFL). Ind-Ra has also affirmed the ‘IND A1+’ rating on the commercial paper programmes of MOFSL, MOFL and Motilal Oswal Wealth Limited (MOWL).
Stronger Business Profile
According to Ind-Ra, the upgrade reflects a stronger business profile, driven by the continued scale-up of its asset management and private wealth businesses, rising recurring fee-based revenue, and sustained profitability growth visibility across key operating segments. The agency noted that improved earnings diversification has reduced the group’s relative dependence on transaction-based income, while comfortable capitalisation, adequate liquidity buffers, and the fungibility of liquidity across group entities provide additional financial flexibility.
Future Prospects
A stronger rating widens our access to diversified funding and should support greater efficiency in our cost of borrowing as we scale our lending, housing finance, and wealth businesses with discipline, said Mr. Shalibhadra Shah, Group Chief Financial Officer, Motilal Oswal Financial Services Limited. With this rating upgrade, we are now rated AA+ from all the three leading rating agencies in India.
The upgrade is an independent recognition of the transformation of Motilal Oswal, said Mr. Motilal Oswal, Managing Director and CEO & co-founder, Motilal Oswal Financial Services Limited. This upgrade belongs to the more than 15 million clients who trust us, to our franchise partners, and to our people, and it strengthens our resolve to build an institution that compounds trust as patiently as it compounds wealth.
Source: NSE Corporate Announcement
Fundamental & Technical Analysis of Motilal Oswal Financial Services Limited
Motilal Oswal Financial Services Limited belongs to the Financial Services › Capital Markets sector. Here’s a quick read on where the business and the stock stand today.
Motilal holds in the upper half of its 52-week range, a sign the market backs the stock. D/E of 1.32 is elevated. As a result, debt servicing will compress free cash flow in a high-rate environment. Premium net margins of 23.0% demonstrate strong cost discipline and a wide competitive moat. Buyers show up with 1.8x the volume of sellers. Moreover, they dominated on 16 of recent sessions versus 14 for sellers — a healthy accumulation pattern. Both the business and the stock move in the right direction. Revenue grows at 29.1%, profits at 26.1%, and the PEG sits at 1.12 — below its growth rate. That combination is rare. Check Fundamentals of Motilal Oswal Financial Services Limited.
Banks - Regional
Indusind Bank Limited Expands HYROX India Partnership to Multiple Cities
IndusInd Bank Limited (INDUSINDBK) expands its partnership with HYROX India, offering exclusive benefits to customers across multiple cities.
IndusInd Bank Limited (INDUSINDBK) has expanded its partnership with HYROX India, spanning across multiple cities including Ahmedabad, Bengaluru, and Noida. This strategic move aims to strengthen the bank’s connection with fitness enthusiasts and experience-seeking consumers, offering exclusive cashback offers and race-day benefits.
Exclusive Benefits for Customers
Customers will enjoy priority check-in, dedicated access lanes, exclusive event privileges, and curated on-ground experiences. This partnership reflects IndusInd Bank’s commitment to engaging with a generation that values aspiration, perseverance, and continuous progress.
Strategic Partnership
Speaking on the partnership, Sheran Mehra, Chief Marketing Officer, IndusInd Bank, said, ‘HYROX gives IndusInd Bank an opportunity to engage with a generation that values aspiration, perseverance, and continuous progress. This partnership is therefore more than a sports association; it is a strategic platform to deepen relevance, create distinctive experiences, and become part of the lives of consumers who are always striving for what’s next.’
Source: NSE Corporate Announcement
Fundamental & Technical Analysis of IndusInd Bank Limited
IndusInd Bank Limited belongs to the Financial Services › Banks – Regional sector. Here’s a quick read on where the business and the stock stand today.
IndusInd posts a 2.2% three-month gain, but softens in the last few weeks. Thin margins at 7.6% leave limited room for error — any demand softness or cost spike hits the bottom line hard. Revenue contracts at -0.4% CAGR. That signals structural headwinds, not a short-term blip. The stock gives back 6.3% in the last month despite a positive three-month run. As a result, the earlier momentum appears to be fading. Revenue grows at -0.4% CAGR and the PEG stands at 99.00. The growth does not match the price the market asks. Furthermore, flat price action adds no technical catalyst. A lower price or faster revenue growth would improve the odds. Check Fundamentals of IndusInd Bank Limited.
Credit Services
Ugro Capital Raises INR 380 Crore from FMO; Third Investment in Three Years Deepens Development Finance Backing for India’s MSME Credit Gap
Ugro Capital Limited (UGROCAP) secures INR 380 crore from FMO, marking its third investment in three years, to support India’s MSME sector.
UGRO Capital Limited (NSE: UGROCAP) announced today that it has raised INR 380 crore through the issuance of senior, secured, rated, listed, redeemable and transferable Non-Convertible Debentures (NCDs), fully subscribed by Nederlandse Financierings-Maatschappij voor Ontwikkelingslanden N.V. (FMO), the Dutch entrepreneurial development bank. This marks FMO’s third investment in UGRO Capital in under three years, following NCD investments of INR 250 crore in December 2023 and INR 260 crore in February 2025. The five-year tenor of the new instrument matches the long-duration secured lending that UGRO extends to small businesses in Tier-3 towns and beyond.
Strategic Investment
The investment continues UGRO Capital’s strategy of building a diversified, long-tenor institutional funding base that is less dependent on the domestic banking system. The Company has now raised over INR 1,300 crore of debt from development finance institutions and impact-focused investors in India and globally, including FMO, IFU, the Danish sovereign development fund, the Asian Development Bank (ADB), Triple Jump, BlueOrchard, responsAbility, Calvert Impact Capital, Enabling Qapital, GMO, WaterEquity and MicroVest, among others.
Impactful Financing
In line with FMO’s mandate, the proceeds will be deployed towards financing for women-owned and women-led SMEs, youth-owned and youth-led SMEs and rural SMEs, and will also contribute towards the financing or refinancing of eligible green projects aligned with FMO’s sustainability approach. UGRO Capital serves the segment of Indian enterprise that the formal credit system has historically been unable to reach: businesses with turnover below INR 3 crore that lack the tax and audited records conventional lenders require.
Source: NSE Corporate Announcement
Fundamental & Technical Analysis of Ugro Capital Limited
Ugro Capital Limited belongs to the Financial Services › Credit Services sector. Here’s a quick read on where the business and the stock stand today.
Ugro falls 14.1% over three months and has not found a floor yet. The PEG of 0.09 is extremely low. Either the market misses the growth story, or there is a catch worth investigating. Premium net margins of 24.0% demonstrate strong cost discipline and a wide competitive moat. RSI stands at 29, well into oversold territory. Yet sellers still dominated on 19 of recent sessions versus 11 for buyers, so the pressure has not fully lifted. Revenue grows at 42.4% and profits at 63.8% CAGR, with D/E of 0.00. Meanwhile, the stock dips 14.1% in three months without any fundamental deterioration. Consequently, the stock quietly becomes cheaper relative to earnings power. For long-term investors, that is a feature. Check Fundamentals of Ugro Capital Limited.
-
CUMMINSIND3 days agoCummins India Limited (cumminsind) Unveils Next-generation Power Solutions at Bauma Conexpo India 2026
-
Industrials2 days agoWestern Carriers (india) Limited Launches Bulk Tiles Train at Morbi Terminal
-
Auto Parts3 days agoUno Minda Limited Announces Four Major Strategic Expansions with ₹1,415 Crore Investment
-
CARTRADE3 days agoCartrade Tech Limited (cartrade) Expands OLX India’s Elite Buyer for Businesses
-
AUROPHARMA3 days agoAurobindo Pharma Limited Receives Final Approval for Beclomethasone Dipropionate HFA Inhalation Aerosol
-
RATEGAIN2 days agoRategain Travel Technologies Limited Unveils Key Findings from the State of Distribution 2026 Report
-
EMBDL3 days agoEmbassy Developments Limited (embdl) Launches Embassy Origins in North Bengaluru
-
Basic Materials2 days agoS H Kelkar and Company Limited (SHK) Mourns the Loss of Chairman Mr. Ramesh Vinayak Vaze